THE WIRE · UPDATED 4:40 PM MDT No story is too small.
Salt Lake City

ARUP launches first Clinical Spectral Flow Cytometry assay for MRD assessment in Multiple Myeloma

Single source Reported from one source.
ARUP launches first Clinical Spectral Flow Cytometry assay for MRD assessment in Multiple Myeloma
Photo via utahbusiness.com
Read at utahbusiness.com →

Utah News spotted this story at utahbusiness.com. Full coverage may follow as more sources report.

SALT LAKE CITY — ARUP Laboratories announced the launch of ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry. “We are harnessing a technology that’s relatively new in the diagnostic space,” said Madhu Menon, MD, PhD, FCAP, FASCP, head of clinical operations for Hematopathology at ARUP.

Article details

CitySalt Lake City